Skip to main content
NCBI home page
The Canadian Veterinary Journal logoLink to The Canadian Veterinary Journal
. 1992 Nov;33(11):734–741.

The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves

Richard J Harland, Andrew A Potter, Sylvia van Drunen-Littel-van den Hurk, Joyce Van Donkersgoed, Michael D Parker, Timothy J Zamb, Eugene D Janzen
PMCID: PMC1481421  PMID: 17424116

Abstract

The efficacy of a Pasteurella haemolytica vaccine (PhV) administered once to calves within 24 hours of arrival at a feedlot was tested for the ability to prevent morbidity and mortality from all bovine respiratory disease (BRD) and specifically from fibrinous pneumonia mortality. The PhV consisted of two immunizing ingredients: outer membrane proteins extracted from P. haemolytica, plus genetically attenuated leukotoxin produced by recombinant DNA technology. This double blind study was conducted at a large Saskatchewan feedlot using 2,324 high-risk calves purchased at auction markets and kept under typical commercial feedlot conditions. The trial design included four vaccine test groups: 1) PhV and a bovine herpesvirus type-1 (BHV-1) subunit vaccine comprised only of the virus glycoprotein IV (gIV); 2) PhV and a commercial modified live vaccine (MLV) containing BHV-1 and parainfluenza-3 viruses; 3) gIV alone; and 4) MLV alone. Calves were assigned to vaccine groups in a random systematic manner, individually identified, and monitored for 90 days after vaccination. The vaccines were given once, on arrival, to reflect common feedlot practice, although vaccination prior to expected risk would be more appropriate.

The PhV in combination with gIV reduced BRD morbidity by 20% (p < 0.05) compared to gIV alone and 24% (p < 0.05) compared to MLV alone, and reduced BRD mortality by 88% (p < 0.05) and fibrinous pneumonia mortality by 100% (p < 0.05) when compared to either gIV or MLV alone. Vaccination with PhV in combination with MLV significantly reduced the efficacy of the PhV in preventing BRD morbidity, BRD mortality, and fibrinous pneumonia mortality and also reduced the antibody response to P. haemolytica leukotoxin. These results suggest that the MLV interfered with the protective capacity of the PhV.

Full text

PDF
734

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander B. H., MacVean D. W., Salman M. D. Risk factors for lower respiratory tract disease in a cohort of feedlot cattle. J Am Vet Med Assoc. 1989 Jul 15;195(2):207–211. [PubMed] [Google Scholar]
  2. Babiuk L. A., L'Italien J., van Drunen Littel-van den Hurk S., Zamb T., Lawman J. P., Hughes G., Gifford G. A. Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology. 1987 Jul;159(1):57–66. doi: 10.1016/0042-6822(87)90347-3. [DOI] [PubMed] [Google Scholar]
  3. Bateman K. G. Efficacy of a pasteurella haemolytica vaccine/bacterial extract in the prevention of bovine respiratory disease in recently shipped feedlot calves. Can Vet J. 1988 Oct;29(10):838–839. [PMC free article] [PubMed] [Google Scholar]
  4. Church T. L., Radostits O. M. A retrospective survey of diseases of feedlot cattle in Alberta. Can Vet J. 1981 Feb;22(2):27–30. [PMC free article] [PubMed] [Google Scholar]
  5. Confer A. W., Lessley B. A., Panciera R. J., Fulton R. W., Kreps J. A. Serum antibodies to antigens derived from a saline extract of Pasteurella haemolytica: correlation with resistance to experimental bovine pneumonic pasteurellosis. Vet Immunol Immunopathol. 1985 Nov;10(2-3):265–278. doi: 10.1016/0165-2427(85)90052-2. [DOI] [PubMed] [Google Scholar]
  6. Confer A. W., Panciera R. J., Mosier D. A. Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica. J Am Vet Med Assoc. 1988 Nov 15;193(10):1308–1316. [PubMed] [Google Scholar]
  7. Conlon J. A., Shewen P. E., Lo R. Y. Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1. Infect Immun. 1991 Feb;59(2):587–591. doi: 10.1128/iai.59.2.587-591.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frank G. R., Salman M. D., MacVean D. W. Use of a disease reporting system in a large beef feedlot. J Am Vet Med Assoc. 1988 Apr 15;192(8):1063–1067. [PubMed] [Google Scholar]
  9. Frerichs G. N., Woods S. B., Lucas M. H., Sands J. J. Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines. Vet Rec. 1982 Aug 7;111(6):116–122. doi: 10.1136/vr.111.6.116. [DOI] [PubMed] [Google Scholar]
  10. Gentry M. J., Confer A. W., Panciera R. J. Serum neutralization of cytotoxin from Pasteurella haemolytica, serotype 1 and resistance to experimental bovine pneumonic pasteurellosis. Vet Immunol Immunopathol. 1985 Jul;9(3):239–250. doi: 10.1016/0165-2427(85)90074-1. [DOI] [PubMed] [Google Scholar]
  11. Harland R. J., Jim G. K., Guichon P. T., Townsend H. G., Janzen E. D. Efficacy of parenteral antibiotics for disease prophylaxis in feedlot calves. Can Vet J. 1991 Mar;32(3):163–168. [PMC free article] [PubMed] [Google Scholar]
  12. Harris F. W., Janzen E. D. The Haemophilus somnus disease complex (Hemophilosis): A review. Can Vet J. 1989 Oct;30(10):816–822. [PMC free article] [PubMed] [Google Scholar]
  13. Janzen E. D. Clinical management of bovine respiratory disease. Can Vet J. 1991 Apr;32(4):215–218. [PMC free article] [PubMed] [Google Scholar]
  14. Janzen E. D., Smart J. N., Nicholson H. H. Observations on an outbreak of infectious bovine rhinotracheitis in a bull test station. Can Vet J. 1980 Jan;21(1):24–27. [PMC free article] [PubMed] [Google Scholar]
  15. Jensen R., Pierson R. E., Braddy P. M., Saari D. A., Lauerman L. H., England J. J., Keyvanfar H., Collier J. R., Horton D. P., McChesney A. E. Shipping fever pneumonia in yearling feedlot cattle. J Am Vet Med Assoc. 1976 Sep 1;169(5):500–506. [PubMed] [Google Scholar]
  16. Kelly A. P., Janzen E. D. A review of morbidity and mortality rates and disease occurrence in north american feedlot cattle. Can Vet J. 1986 Dec;27(12):496–500. [PMC free article] [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Lee L. F., Sharma J. M., Nazerian K., Witter R. L. Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkeys. Infect Immun. 1978 Aug;21(2):474–479. doi: 10.1128/iai.21.2.474-479.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lessley B. A., Confer A. W., Mosier D. A., Gentry M. J., Durham J. A., Rummage J. A. Saline-extracted antigens of Pasteurella haemolytica: separation by chromatofocusing, preliminary characterization, and evaluation of immunogenicity. Vet Immunol Immunopathol. 1985 Nov;10(2-3):279–296. doi: 10.1016/0165-2427(85)90053-4. [DOI] [PubMed] [Google Scholar]
  20. Markham R. J., Wilkie B. N. Interaction between Pasteurella haemolytica and bovine alveolar macrophages: cytotoxic effect on macrophages and impaired phagocytosis. Am J Vet Res. 1980 Jan;41(1):18–22. [PubMed] [Google Scholar]
  21. Martin S. W., Meek A. H., Davis D. G., Johnson J. A., Curtis R. A. Factors associated with morbidity and mortality in feedlot calves: the Bruce County beef project, year two. Can J Comp Med. 1981 Apr;45(2):103–112. [PMC free article] [PubMed] [Google Scholar]
  22. Martin S. W., Meek A. H., Davis D. G., Thomson R. G., Johnson J. A., Lopez A., Stephens L., Curtis R. A., Prescott J. F., Rosendal S. Factors associated with mortality in feedlot cattle: the Bruce County Beef Cattle Project. Can J Comp Med. 1980 Jan;44(1):1–10. [PMC free article] [PubMed] [Google Scholar]
  23. Martin S. W. Vaccination: Is it Effective in Preventing Respiratory Disease or Influencing Weight Gains in Feedlot Calves? Can Vet J. 1983 Jan;24(1):10–19. [PMC free article] [PubMed] [Google Scholar]
  24. McKinney K. L., Confer A. W., Rummage J. A., Gentry M. J., Durham J. A. Pasteurella haemolytica: purification of saline-extractable proteins by isoelectrofocusing. Vet Microbiol. 1985 Aug;10(5):465–480. doi: 10.1016/0378-1135(85)90028-8. [DOI] [PubMed] [Google Scholar]
  25. Mosier D. A., Confer A. W., Panciera R. J. The evolution of vaccines for bovine pneumonic pasteurellosis. Res Vet Sci. 1989 Jul;47(1):1–10. [PubMed] [Google Scholar]
  26. Shewen P. E., Wilkie B. N. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect Immun. 1982 Jan;35(1):91–94. doi: 10.1128/iai.35.1.91-94.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shewen P. E., Wilkie B. N. Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Can J Vet Res. 1988 Jan;52(1):30–36. [PMC free article] [PubMed] [Google Scholar]
  28. Thorlakson B., Martin W., Peters D. A field trial to evaluate the efficacy of a commercial Pasteurella haemolytica bacterial extract in preventing bovine respiratory disease. Can Vet J. 1990 Aug;31(8):573–579. [PMC free article] [PubMed] [Google Scholar]
  29. Tizard I. Risks associated with use of live vaccines. J Am Vet Med Assoc. 1990 Jun 1;196(11):1851–1858. [PubMed] [Google Scholar]
  30. Van Donkersgoed J., Janzen E. D., Harland R. J. Epidemiological features of calf mortality due to hemophilosis in a large feedlot. Can Vet J. 1990 Dec;31(12):821–825. [PMC free article] [PubMed] [Google Scholar]
  31. Vydelingum S., Ilonen J., Salonen R., Marusyk R., Salmi A. Infection of human peripheral blood mononuclear cells with a temperature-sensitive mutant of measles virus. J Virol. 1989 Feb;63(2):689–695. doi: 10.1128/jvi.63.2.689-695.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Whetstone C. A., Wheeler J. G., Reed D. E. Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am J Vet Res. 1986 Aug;47(8):1789–1795. [PubMed] [Google Scholar]
  33. Yates W. D. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med. 1982 Jul;46(3):225–263. [PMC free article] [PubMed] [Google Scholar]
  34. van Drunen Littel-van den Hurk S., Gifford G. A., Babiuk L. A. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine. 1990 Aug;8(4):358–368. doi: 10.1016/0264-410x(90)90095-4. [DOI] [PubMed] [Google Scholar]
  35. van Drunen Littel-van den Hurk S., van den Hurk J. V., Gilchrist J. E., Misra V., Babiuk L. A. Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology. 1984 Jun;135(2):466–479. doi: 10.1016/0042-6822(84)90201-0. [DOI] [PubMed] [Google Scholar]

Articles from The Canadian Veterinary Journal are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES